Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU6-556P is a pseudogene corresponding to the U6 small nuclear RNA (snRNA) gene family in humans. U6 snRNA is an essential component of the spliceosome, a complex responsible for pre-mRNA splicing, but pseudogenes like RNU6-556P do not encode functional RNAs. Pseudogenes are generally considered non-coding genomic DNA that resemble functional genes but have lost their protein-coding ability or functionality due to mutations. However, in some cases, pseudogenes can play regulatory roles or act as decoys for microRNAs. There is no evidence that RNU6-556P encodes a functional product or has distinct biological or clinical relevance[2][3]. The existence of many U6 snRNA pseudogenes reflects the evolutionary importance and prevalence of the functional U6 snRNA gene in the human genome[3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 556, pseudogene (RNU6-556P).